Seamon Kyle J, Sun Zhiqiang, Shlyakhtenko Luda S, Lyubchenko Yuri L, Stivers James T
Department of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, 725 North Wolfe Street, Baltimore, MD 21205-2185, USA.
Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, 986025 Nebraska Medical Center, Omaha, NE 68198-6025, USA.
Nucleic Acids Res. 2015 Jul 27;43(13):6486-99. doi: 10.1093/nar/gkv633. Epub 2015 Jun 22.
The HIV-1 restriction factor SAMHD1 is a tetrameric enzyme activated by guanine nucleotides with dNTP triphosphate hydrolase activity (dNTPase). In addition to this established activity, there have been a series of conflicting reports as to whether the enzyme also possesses single-stranded DNA and/or RNA 3'-5' exonuclease activity. SAMHD1 was purified using three chromatography steps, over which the DNase activity was largely separated from the dNTPase activity, but the RNase activity persisted. Surprisingly, we found that catalytic and nucleotide activator site mutants of SAMHD1 with no dNTPase activity retained the exonuclease activities. Thus, the exonuclease activity cannot be associated with any known dNTP binding site. Monomeric SAMHD1 was found to bind preferentially to single-stranded RNA, while the tetrameric form required for dNTPase action bound weakly. ssRNA binding, but not ssDNA, induces higher-order oligomeric states that are distinct from the tetrameric form that binds dNTPs. We conclude that the trace exonuclease activities detected in SAMHD1 preparations arise from persistent contaminants that co-purify with SAMHD1 and not from the HD active site. An in vivo model is suggested where SAMHD1 alternates between the mutually exclusive functions of ssRNA binding and dNTP hydrolysis depending on dNTP pool levels and the presence of viral ssRNA.
HIV-1限制因子SAMHD1是一种由鸟嘌呤核苷酸激活的具有三磷酸脱氧核苷酸水解酶活性(dNTPase)的四聚体酶。除了这种已确定的活性外,关于该酶是否还具有单链DNA和/或RNA 3'-5'核酸外切酶活性,一直存在一系列相互矛盾的报道。通过三步层析法纯化SAMHD1,在此过程中,DNase活性与dNTPase活性在很大程度上得以分离,但RNase活性仍然存在。令人惊讶的是,我们发现没有dNTPase活性的SAMHD1催化和核苷酸激活位点突变体仍保留核酸外切酶活性。因此,核酸外切酶活性与任何已知的dNTP结合位点均无关。发现单体SAMHD1优先结合单链RNA,而dNTPase作用所需的四聚体形式结合较弱。ssRNA结合而非ssDNA结合会诱导形成与结合dNTP的四聚体形式不同的高阶寡聚状态。我们得出结论,在SAMHD1制剂中检测到的微量核酸外切酶活性源自与SAMHD1共纯化的持久性污染物,而非来自HD活性位点。提出了一种体内模型,其中SAMHD1根据dNTP池水平和病毒ssRNA的存在,在ssRNA结合和dNTP水解这两种相互排斥的功能之间交替。